Skip to main content
Clinical Trials/CTRI/2025/08/093613
CTRI/2025/08/093613
Not yet recruiting
Not Applicable

A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions

Not provided1 site in 1 country500 target enrollmentStarted: September 5, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
500
Locations
1
Primary Endpoint
1. Intended target lesion and/or marker removal, independent of margin status on final

Overview

Brief Summary

This is a multivcentre international observational study. The aim of the proposed study is to comparatively evaluate different imaging-guided localization methods used for surgical removal of non-palpable malignant breast lesions with regard to oncological safety and patient-reported outcomes.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Signed consent
  • Malignant breast lesion requiring breast-conserving surgery and imaging-guided localization (either DCIS or invasive breast cancer; multiple or bilateral lesions and the use of neoadjuvant chemotherapy are allowed)
  • Planned surgical removal of the lesion using one or more of the following imaging guided localization techniques (Wire, intraoperative USG, Dye, seed).

Exclusion Criteria

  • Patients not suitable for surgical treatment
  • Patients requiring mastectomy as first surgery
  • Surgical removal without imaging-guided localization.

Outcomes

Primary Outcomes

1. Intended target lesion and/or marker removal, independent of margin status on final

Time Frame: 1. At Baseline before image-guided localisation | 2. During Surgery | 3. At 2 weeks after Surgery | 4. At 4 weeks after Surgery

histopathology

Time Frame: 1. At Baseline before image-guided localisation | 2. During Surgery | 3. At 2 weeks after Surgery | 4. At 4 weeks after Surgery

2. Negative resection margin rates (defined as lesion removal with no invasive or

Time Frame: 1. At Baseline before image-guided localisation | 2. During Surgery | 3. At 2 weeks after Surgery | 4. At 4 weeks after Surgery

non-invasive carcinoma on ink) at first surgery

Time Frame: 1. At Baseline before image-guided localisation | 2. During Surgery | 3. At 2 weeks after Surgery | 4. At 4 weeks after Surgery

Secondary Outcomes

  • - Rates of second surgery, mastectomy, resection ratio, marker dislocation rates(- Volume and weight of resected tissue)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Jyoutishman Saikia

AIIMS New Delhi

Study Sites (1)

Loading locations...

Similar Trials